Results 221 to 230 of about 224,268 (252)

[Management of chronic coronary syndrome].

Herz, 2022
Coronary artery disease remains the leading cause of death in developed countries. This CME article addresses and comments on important aspects from the current guidelines for the diagnosis and management of chronic coronary syndrome of the European Society of Cardiology (ESC) and the current guidelines for the evaluation and diagnosis of chest pain of
Udo, Sechtem, Andreas, Seitz, Peter, Ong, Raffi, Bekeredjian   +3 more
openaire   +1 more source

Antithrombotic therapy for patients with chronic coronary syndromes

Heart, 2020
### Learning objectives Globally, much morbidity and premature mortality arises from coronary artery disease (CAD). Coronary artery atherothrombosis is the dominant cause of acute coronary syndromes (ACS), including spontaneous myocardial infarction (MI) and unstable angina.
William AE Parker, Robert F Storey
openaire   +2 more sources

Coronary Atherosclerosis: Chronic Coronary Syndromes

2002
Coronary heart disease is widely prevalent and the greatest cause of mortality and morbidity in the United States [1–3]. Between 45% and 70% of war casualties in Korea and Vietnam, averaging 26 years of age, demonstrated coronary atherosclerosis at postmortem examination with 15%–20% having stenoses of 50% luminal area narrowing or greater [4–7 ...
openaire   +1 more source

Coronary microvascular dysfunction beyond the spectrum of chronic coronary syndromes

Progress in Cardiovascular Diseases
The prevalence of coronary microvascular dysfunction (CMD) beyond the spectrum of chronic coronary syndromes (CCS) is non-negligible, pertaining to pathophysiological and therapeutical implications. Thanks to the availability of accurate and safe non-invasive technique, CMD can be identified as a key player in heart failure, cardiomyopathies, Takotsubo
Marta Belmonte, MD1, Alberto Foà, MD PhD2, Pasquale Paolisso, MD PhD3, Luca Bergamaschi, MD2, Emanuele Gallinoro, MD PhD3, Alberto Polimeni, MD4 5, Roberto Scarsini, MD PhD6, Saverio Muscoli, MD PhD7, Sara Amicone, MD2, Antonio De Vita, MD8, Angelo Villano, MD8, Francesco Angeli, MD2, Matteo Armillotta, MD2, Vincenzo Sucato, MD9, Saverio Tremamunno, MD10, Doralisa Morrone, MD PhD11, Ciro Indolfi, MD PhD12, 13, Pasquale Perrone Filardi, MD PhD1, Flavio Ribichini MD, PhD6, Gaetano Antonio Lanza, MD8, Alaide Chieffo, MD14 15, Emanuele Barbato, MD, PhD16 and Carmine Pizzi, MD2 on behalf of the Coronary Physiopathology and Microcirculation Working Group of the Italian Society of Cardiology (SIC).   +46 more
openaire   +2 more sources

Antithrombotic Therapy in Patients with Chronic Coronary Syndromes

Interventional Cardiology Clinics
The antithrombotic management of chronic coronary syndrome (CCS) involves a 6-month course of dual antiplatelet therapy (DAPT), followed by chronic aspirin therapy. In patients with a baseline indication for anticoagulation, a variable duration of triple antithrombotic therapy is administered, followed by dual antithrombotic therapy until the sixth ...
Placido Maria, Mazzone, Marco, Spagnolo, Davide, Capodanno   +2 more
openaire   +2 more sources

Efficacy of Ticagrelol in chronic coronary syndrome

International Journal of Life Science Research Archive, 2022
Chronic coronary syndrome is one of the pressing issues of cardiology. Despite advancements in healthcare, the problem remains one of the concerning issues of the medicine. Lately different antiplatelet have being used to treat patients with chronic coronary syndrome including P2Y12 inhibitors.
openaire   +1 more source

Acute Coronary Syndromes in Patients with Chronic Kidney Disease

Current Vascular Pharmacology, 2013
Chronic kidney disease (CKD) is associated with high cardiovascular morbidity and mortality. The available data suggest that efforts to reduce mortality in the CKD population should be focused on treatment and prevention of, among others, coronary artery disease and congestive heart failure.
Beata, Franczyk-Skóra, Anna, Gluba, Maciej, Banach, Piotr, Rozentryt, Lech, Poloński, Jacek, Rysz   +5 more
openaire   +2 more sources

[The Role of Percutaneous Coronary Revascularization in Chronic Coronary Syndromes].

Praxis, 2021
The Role of Percutaneous Coronary Revascularization in Chronic Coronary Syndromes Abstract. Coronary heart disease represents the leading cause of morbidity and mortality worldwide. Optimal management of these patients is therefore crucial and includes lifestyle changes, optimal medical therapy, and coronary revascularization.
Philipp, Jakob, Erik W, Holy, Patrick, Siegrist, Jonathan, Michel, Robert, Manka, Markus, Kasel, Willibald, Maier, Frank, Ruschitzka, Christian, Templin, Barbara E, Stähli   +9 more
openaire   +1 more source

Editorial: Coronary artery aneurysms in chronic coronary syndromes

Cardiovascular Revascularization Medicine, 2023
Nauman, Khalid, Sarah Aftab, Ahmad
openaire   +2 more sources

[Contribution of coroscanner in chronic coronary syndrome].

Annales de cardiologie et d'angeiologie, 2022
Cardiac division imaging by coroscanner has progressed a lot in 20 years to gradually become an important and potentially indispensable tool of chronic coronary cardiology. The European and American recommendations are Grade I for the assessment of symptomatic patients at intermediate to high risk, at the same level as traditional functional tests. The
Patrick, Dupouy, Jean Marc, Pernes
openaire   +1 more source